blocker antihypertensive agent. The aim of the present study investigation was to develop a Lipid Based Formulation (LBF) to enhance the dissolution as well as the oral bioavailability of poorly
present study was designed to develop a suitable matrix type transdermal drug delivery system (TDDS) of Aceclofenac using blends of three different polymeric combinations of Polyvinyl pyrrolidine (PVP) and…
objective of this study was to develop effective mucoadhesive buccal bilayered tablets of a drug containing bioadhesive layer and drug free backing layer, expected to release the drug in unidirection ... studies…
specific, accurate, precise and reproducible stabilityindicating HPLC method has been developed and subsequently validated for the simultaneous determination of pantoprazole, rabeprazole, lansoprazole and domperidone in…
acyclovir as single-unit floating capsules. Low-density polymers were used for formulation and development of these floating capsules. The capsules were prepared by physical blending of acyclovir and various
gastroretentive, controlled release drug delivery system of Cefixime trihydrate was formulated in an effort to increase the gastric retention time of the dosage form and to control drug release. Various ... drug was…
agents. Recently, in this field nanotechnology represents a modern and innovative approach to develop new formulations based on metallic nanoparticles with antimicrobial properties. The bacterial growth curve, minimum…
lowering agent. A Small Tablet (ST) formulation and a Chewable Tablet (CT) formulation have recently been developed and tested in two single-dose bioequivalent (BE) studies ... ortho-hydroxyatorvastatin in CT studies…
stomach, duodenum and jejunum. Some of the unresolved, critical issues related to the rational development of FDDS include (1) the quantitative efficiency of floating delivery systems in the fasted ... correlation…
liposomes and polymeric micro and nanoparticles. The purpose of this research work was to develop and evaluate solid lipid microparticles of sirolimus for oral delivery. Sirolimus is an immunosupressive drug ... while…
drug is prohibitive especially in the developing countries. The aim of this study is to compare pharmacokinetics profile of a new Imatinib generic formulation (Imatinib tablets 400mg batch number
respectively. To explain the observed differences in BA, a pharmacokinetic-pharmacodynamic model was developed and BAs were predicted at different doses of inhalation insulin with the fixed 10 IU subcutaneous ... were…
Pharmacokinetics and bioavailability of a chewable tablet formulation of sildenafil citrate 100 mg developed using taste-masking technology and taken with or without water (chewed until full disintegration and then
development of new drugs as API manufacturing process and formulation options keep changing during the entire drug development paradigm. It is needless to say that BA/ BE considerations has gone ... measure of the…
infections. Lamivudine, CAS 134678-17-4 is a nucleoside analogue reverse transcriptase inhibitor developed as a treatment for HIV infection and also with activity against hepatitis B virus. The combination ... extent of…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.